Uma Sinha Eidos Therapeutics, Inc. (EIDX) insider trading activity

Uma Sinha is Chief Scientific Officer of Eidos Therapeutics, Inc.. Currently has a direct ownership of 0 shares of EIDX, which is worth approximately $0. The most recent transaction as insider was on Jan 26, 2021, when has been sold 303,525 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Uma Sinha Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 26 2021	SELL Disposition due to a tender of shares in a change of control transaction	-	303,525 Reduced 100.0%	0 Common Stock
Jan 13 2021	SELL Open market or private sale	$1,238,900 $123.89 p/Share	10,000 Reduced 3.16%	306,525 Common Stock
Dec 02 2020	SELL Open market or private sale	$456,400 $91.28 p/Share	5,000 Reduced 1.56%	316,525 Common Stock
Oct 29 2020	SELL Open market or private sale	$361,250 $72.25 p/Share	5,000 Reduced 1.53%	321,525 Common Stock
Oct 27 2020	SELL Bona fide gift	-	3,000 Reduced 0.98%	303,525 Common Stock
Oct 01 2020	SELL Open market or private sale	$252,903 $52.35 p/Share	4,831 Reduced 1.46%	326,525 Common Stock
Sep 30 2020	SELL Open market or private sale	$8,795 $52.04 p/Share	169 Reduced 0.05%	331,356 Common Stock

Also insider at

BBIO

BridgeBio Pharma, Inc. Healthcare

Chief Scientific Officer

DNAC

Social Capital Suvretta Holdings Corp. III

Uma Sinha

Chief Scientific Officer

Winston Salem, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EIDX shares.

Notify only if

Value

Insider Trading

Get notified when an Eidos Therapeutics, Inc. insider buys or sells EIDX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Eidos Therapeutics, Inc.

Track Activities on EIDX

Account